Cite
APA Citation
Oh, S. J., Shcherbakova, N., Kostera‐Pruszczyk, A., Alsharabati, M., Dimachkie, M., Blanco, J. M., Brannagan, T., Lavrnić, D., Shieh, P. B., Vial, C., Meisel, A., Komoly, S., Schoser, B., Sivakumar, K., So, Y., & , (2016). amifampridine phosphate (Firdapse®) is effective and safe in a phase 3 clinical trial in LEMS. Muscle & nerve, 53(5), 717–725. http://access.bl.uk/ark:/81055/vdc_100031981427.0x000047